arboxylic acid (3-hydroxynaphthalen-2-yl)amide; glycogen phosphorylase inhibitors useful in treating, preventing or slowing progression of diseases requiring glycogen phosphorylase inhibitor therapy such as diabetes and hyperglycemiaUS722694214 Nov 20055 Jun 2007Bristol-Myers Squibb Company2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitorsUS7253203 *17 Mar